2013-01-09 13:44:10 - Significant growth in cardiac resynchronization therapy devices is likely to drive the US cardiac rhythm management market in future, says RNCOS.
According to a new research report by RNCOS, “US Cardiac Device Market Analysis”, the US has been witnessing an uprise in the incidences of cardiovascular-related complications and therefore the cardiac medical devices sector is a current industry focus. As the population is getting older, this trend is expected to continue in future also, thereby supporting the prominent growth in the sector. With the total size hovering around US$ 17.5 Billion in 2011, the market is further expected to perform good in coming years also with technological upgradation playing a key role.
As per our report, the US cardiac rhythm management devices market which includes pacemakers, defibrillators, and cardiac resynchronization therapy devices, has grown significantly in recent times fueled by demographic, technologic,
and economic factors and is further expected to grow at a healthy CAGR of 8.16% during 2011-2015. The US cardiac rhythm management market is dominated by implanted coronary defibrillators, followed by cardiac resynchronization therapy devices and pacemakers. In future, a significant growth is likely to emanate from cardiac resynchronization therapy devices as the high incidences of congestive heart failure shall support the sector.
The report, which is spread in over 70 pages, prudently analyzes the current performance of market segments (cardiac rhythm management, interventional cardiology and cardiovascular surgery) and the share of other sub-segments. It also elaborates, in detail, regulatory landscape with regards to cardiac medical devices in the US and the role of key authorities/association in the decision making process.
The report is an outcome of an extensive research and rational analysis of the current status and expected position of the US cardiac medical devices market. It facilitates the future forecasts on overall US cardiac medical devices market size during 2012-2015. It also covers an in-depth analysis of the competitive landscape and broadly elaborates about the players in terms of their business description, financial performance, strengths & weaknesses and key activities.
For FREE SAMPLE of this report visit: www.rncos.com/Report/IM441.htm
Some of our Related Reports are:
- US Proton Therapy Market Analysis to 2017 ( www.rncos.com/Report/IM465.htm
- US Personalized Cancer Genome Sequencing Market ( www.rncos.com/Report/IM453.htm
- Brazil Healthcare - New Opportunities for Growth ( www.rncos.com/Report/IM451.htm
- US Non-Invasive Prenatal Diagnostics - Market Insight ( www.rncos.com/Report/IM450.htm
- US Clinical Laboratory Testing Market Assessment ( www.rncos.com/Report/IM442.htm
Check Related REPORTS on: www.rncos.com/Healthcare_Industry.htm
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.